Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors
Authors:
Open Access
- 1 January 2024
- journal article
- review article
- Published by KEAI Publishing in Global Medical Genetics
- Vol. 11 (1) , 86-99
Abstract
The fusion genes NRG1 and NRG2 , members of the epidermal growth factor (EGF) receptor family, have emerged as key drivers in cancer. Upon fusion, NRG1 retains its EGF-like active domain, binds to the ERBB ligand family, and triggers intracellular signaling cascades, promoting uncontrolled cell proliferation. The incidence of NRG1 gene fusion varies across cancer types, with lung cancer being the most prevalent at 0.19 to 0.27%. CD74 and SLC3A2 are the most frequently observed fusion partners. RNA-based next-generation sequencing is the primary method for detecting NRG1 and NRG2 gene fusions, whereas pERBB3 immunohistochemistry can serve as a rapid prescreening tool for identifying NRG1 -positive patients. Currently, there are no approved targeted drugs for NRG1 and NRG2 . Common treatment approaches involve pan-ERBB inhibitors, small molecule inhibitors targeting ERBB2 or ERBB3, and monoclonal antibodies. Given the current landscape of NRG1 and NRG2 in solid tumors, a consensus among diagnostic and treatment experts is proposed, and clinical trials hold promise for benefiting more patients with NRG1 and NRG2 gene fusion solid tumors.Keywords
This publication has 57 references indexed in Scilit:
- γ-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175Oncogene, 1997
- A Novel Brain-Derived Member of the Epidermal Growth Factor Family That Interacts with ErbB3 and ErbB4The Journal of Biochemistry, 1997
- Characterization of a Neuregulin-Related Gene, Don-1, That Is Highly Expressed in Restricted Regions of the Cerebellum and HippocampusMolecular and Cellular Biology, 1997
- Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinasesNature, 1997
- Multiple essential functions of neuregulin in developmentNature, 1995
- ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.Journal of Biological Chemistry, 1994
- Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous systemNature, 1993
- ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand familyCell, 1993
- Identification of Heregulin, a Specific Activator of p185 erbB2Science, 1992
- Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unitCell, 1992